---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-016460"
form_type: "8-K"
ticker: "ADGM"
cik: "0002006986"
company_name: "Adagio Medical Holdings, Inc."
filed_at: "2024-12-23T23:59:59+00:00"
generated_at: "2026-05-28T23:54:02.739658+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Director resigns; Adagio Medical to be non-compliant with Nasdaq audit committee rule

## Summary
- Shahram Moaddeb resigns as director effective Jan 1, 2025, citing demands of other business ventures; no dispute with company.
- Resignation leaves audit committee with a vacancy, triggering non-compliance with Nasdaq Listing Rule 5605(c)(2)(A) as of Jan 1, 2025.
- Company notified Nasdaq on Dec 20, 2024 of expected non-compliance.

## SEC filing metadata
- accession: 0001558370-24-016460
- form_type: 8-K
- ticker: ADGM
- cik: 0002006986
- company_name: Adagio Medical Holdings, Inc.
- filed_at: 2024-12-23T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2006986/000155837024016460/0001558370-24-016460-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2006986/000155837024016460/adgm-20241219x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-016460
- JSON: https://secwatch.observer/filing/0001558370-24-016460.json
- Plain text: https://secwatch.observer/filing/0001558370-24-016460.txt

## Key facts
- Listing & Compliance Notices
  Adagio Medical Holdings, Inc. received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(c)(2)(A)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: audit committee
  - Rules: 5605(c)(2)(A)
  source text: December 20, 2024, Adagio Medical Holdings, Inc., a Delaware corporation (the “Company”), notified the Nasdaq Stock Market LLC (“Nasdaq”) that the Company will not be in compliance with the audit committee requirement under Nasdaq Listing Rule 5605(c)(2)(A) as of January 1, 2025, solely due to a vacancy on the audit committee (the “Audit Committee”) of the Company’s Board of Directors (the “Board”) resulting from Shahram Moaddeb’s resignation from the Board as disclosed in
  evidence_url: https://www.sec.gov/Archives/edgar/data/2006986/000155837024016460/0001558370-24-016460-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.